RT Journal Article
SR Electronic
T1 Phase 2 trial of T-cell activation using MVI-816 and pembrolizumab in patients with metastatic, castration-resistant prostate cancer (mCRPC)
JF Journal for ImmunoTherapy of Cancer
JO J Immunother Cancer
FD BMJ Publishing Group Ltd
SP e004198
DO 10.1136/jitc-2021-004198
VO 10
IS 3
A1 McNeel, Douglas G
A1 Eickhoff, Jens C
A1 Wargowski, Ellen
A1 Johnson, Laura E
A1 Kyriakopoulos, Christos E
A1 Emamekhoo, Hamid
A1 Lang, Joshua M
A1 Brennan, Mary Jane
A1 Liu, Glenn
YR 2022
UL http://jitc.bmj.com/content/10/3/e004198.abstract
AB Markup server — Error Not Found The page you were trying to reach could not be found. Please check the address for the page you were trying to reach. If you believe you have reached this page in error, you may contact us with any questions.